Madelyn Rubenstein

Madelyn Rubenstein, MS, currently serves as Senior Manager of Alliance Leadership at Verge Genomics since May 2023 and as a Part-Time Lecturer at Northeastern University, teaching BIOT 5219: The Biotechnology Enterprise. Prior experience includes roles as Project Manager at Foundation Medicine (June 2020 - May 2023) and Associate Project Manager at Sage Therapeutics (December 2019 - April 2020), where responsibilities involved managing CDx projects and research operations, respectively. Earlier positions encompassed roles at Alnylam Pharmaceuticals, Shire, Boston Children's Hospital, and The Heart Research Institute, contributing to clinical trials, global program management, and research assistance. Madelyn holds a Master's degree in Biotechnology Enterprise from Northeastern University and a Bachelor's degree in Neuroscience from the University of Rochester.